T cell and peripheral blood parameters define progression of autoimmune disease in the IL-2R KO model

IL-2R is required to generate the high affinity receptor for IL-2, a cytokine important in immune proliferation, activation, and regulation. Mice deficient in IL-2R (IL-2R -KO) develop systemic autoimmune disease and die from severe anemia between 18-80 days of age. These mice develop kinetically di...

Full description

Saved in:
Bibliographic Details
Published inbioRxiv
Main Authors Mullins, Genevieve N, Valentine, Kristen M, Al-Kuhlani, Mufadhal, Davini, Dan, Jensen, Kirk Dc, Hoyer, Katrina K
Format Paper
LanguageEnglish
Published Cold Spring Harbor Cold Spring Harbor Laboratory Press 27.06.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:IL-2R is required to generate the high affinity receptor for IL-2, a cytokine important in immune proliferation, activation, and regulation. Mice deficient in IL-2R (IL-2R -KO) develop systemic autoimmune disease and die from severe anemia between 18-80 days of age. These mice develop kinetically differing autoimmune disease, with approximately a quarter dying by 21 days of age and half dying after 30 days. This research aims to define immune parameters that distinguish cohorts of mice that develop early- and late-stage autoimmune disease in the IL-2R -KO genetic background. To investigate these differences, we evaluated complete blood counts (CBC), antibody binding of RBCs, T cell numbers and activation, and hematopoietic progenitor changes, to assess the extent of peripheral autoimmune hemolytic anemia and bone marrow failure. Early onset disease correlated with anti-RBC antibodies and lower hematocrit on day 19. We also found that predicted late stage-disease IL-2R -KO mice have higher numbers of developing memory CD4 and CD8 T cells and reduced AIHA at early ages. The expansion of CD8 T cells seen in IL-2R -KO mice is driven by unimpaired IL-2 signaling which correlated with increased IL-2R expression. Using a simple CBC count we were able to predict disease kinetics to explore mechanisms underlying early and late disease.
DOI:10.1101/345512